Clinical Trial Update: Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fosaprepitant plus a 5-HT3 receptor antagonist and dexamethasone for chemotherapy-induced nausea and vomiting in patients with germ cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Germ Cell Tumors

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)
• Ondansetron (ondansetron)

Snippet

Sponsor: Lawrence Einhorn | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2016-05-25